Venous thrombosis: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Robert Badgett (Added ovarian vein thrombosis) |
||
| Line 4: | Line 4: | ||
==Deep venous thrombosis== | ==Deep venous thrombosis== | ||
{{main|Deep venous thrombosis}} | {{main|Deep venous thrombosis}} | ||
==Ovarian vein thrombosis== | |||
{| class="wikitable" border="1" | |||
|+ Comparison of risk factors amoung women with ovarian vein thrombosis and deep venous thrombosis<ref name="pmid16894453">{{cite journal| author=Wysokinska EM, Hodge D, McBane RD| title=Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival. | journal=Thromb Haemost | year= 2006 | volume= 96 | issue= 2 | pages= 126-31 | pmid=16894453 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16894453 }} </ref> | |||
! !! Ovarian vein thrombosis!! Deep venous thrombosis | |||
|- | |||
| Increased estrogen state<br/>([[Estrogen replacement therapy|ERT]], [[Oral contraceptive|OBCP]], [[pregnancy]])|| 34% || 9% | |||
|- | |||
| Pelvic infection|| 23% || 1% | |||
|- | |||
| Abdominal surgery|| 22% || 4% | |||
|- | |||
| Underlying cancer|| 12% || 15% | |||
|- | |||
| Idiopathic|| 3% || 21% | |||
|} | |||
==Superficial venous thrombousis== | ==Superficial venous thrombousis== | ||
===Prognosis=== | ===Prognosis=== | ||
Revision as of 13:04, 21 February 2011
A venous thrombosis is one of several diseases caused by inappropriate blood clots (thrombi) in veins principally of the arms and legs; thromboses of the pulmonary vein or vena cava are outside the scope of this article. The major area of concern is deep venous thrombosis, although there is also superficial venous thrombosis.
Deep venous thrombosis
Ovarian vein thrombosis
| Ovarian vein thrombosis | Deep venous thrombosis | |
|---|---|---|
| Increased estrogen state (ERT, OBCP, pregnancy) |
34% | 9% |
| Pelvic infection | 23% | 1% |
| Abdominal surgery | 22% | 4% |
| Underlying cancer | 12% | 15% |
| Idiopathic | 3% | 21% |
Superficial venous thrombousis
Prognosis
Superficial venous thrombosis can be associated with deep venous thrombosis and an accompanying deep venous thrombosis occurring simultaneously or later.[2]
Treatment
"Fondaparinux at a dose of 2.5 mg once a day for 45 days was effective in the treatment of patients with acute, symptomatic superficial-vein thrombosis of the legs and did not have serious side effects" according to a randomized controlled trial. [3]
References
- ↑ Wysokinska EM, Hodge D, McBane RD (2006). "Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival.". Thromb Haemost 96 (2): 126-31. PMID 16894453. [e]
- ↑ Decousus H, Quéré I, Presles E, Becker F, Barrellier MT, Chanut M et al. (2010). "Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study.". Ann Intern Med 152 (4): 218-24. DOI:10.1059/0003-4819-152-4-201002160-00006. PMID 20157136. Research Blogging.
- ↑ Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B et al. (2010). "Fondaparinux for the treatment of superficial-vein thrombosis in the legs.". N Engl J Med 363 (13): 1222-32. DOI:10.1056/NEJMoa0912072. PMID 20860504. Research Blogging.